565302-U

Ascentis^® RP-Amide (3 µm) HPLC Columns

L × I.D. 15 cm × 2.1 mm, HPLC Column

• Código UNSPSC: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

Propriedades

• product name: Ascentis^® RP-Amide HPLC Column, 3 μm particle size, L × I.D. 15 cm × 2.1 mm
• Materiais: stainless steel column
• Agency: suitable for USP L60
• linha de produto: Ascentis^®
• Características: endcapped
• fabricante/nome comercial: Ascentis^®
• embalagem: 1 ea of
• Extensão da rotulagem: 19.5% Carbon loading
• Parâmetros: ≤70 °C temp. range; 400 bar pressure (5801 psi)
• técnica(s): HPLC: suitable; LC/MS: suitable
• C × D.I.: 15 cm × 2.1 mm
• área da superfície: 450 m²/g
• cobertura de superfície: 2.7 μmol/m²
• Impurezas: <5 ppm metals
• matriz: fully porous particle; silica gel high purity, spherical
• Grupo ativo da matriz: amide, alkyl phase
• tamanho de partícula: 3 μm
• tamanho de poro: 100 Å
• operating pH range: 2-8
• aplicação(ões): food and beverages
• técnica de separação: reversed phase

Descrição

Descrição geral

The Ascentis family of columns is the fourth generation of HPLC column technology from Supelco scientists. Ascentis columns are bonded on high purity, 100 Angstrom silica including 3, 5, and 10 micron particle size. Columns are designed for small molecule applications and are scalable from micro columns (1.0 mm I.D.) to preparative dimensions (50 mm I.D.). The family includes C18, C8, Phenyl, Si and embedded polar group phase, RP-Amide.

Ascentis RP-Amide is a new generation ultra low bleed, embedded polar group (EPG) phase that provides orthogonal selectivity and increased resolution for HPLC and LC-MS analysis of polar compounds. The Ascentis RP-Amide is the first choice in embedded polar group HPLC phases.

Características e benefícios

• Excellent retention and peak shape for polar compounds
• 100% aqueous compatibility
• Ultra low bleed, LC-MS compatible
• Unique selectivity

Produtos recomendados

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Informações legais

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany